NORCALCIN

Κύριές Πληροφορίες

  • Εμπορική ονομασία:
  • NORCALCIN 100 IU/AMP ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
  • Φαρμακολογική κατηγορία (ATC):
  • H05BA01
  • Δοσολογία:
  • 100 IU/AMP
  • Φαρμακοτεχνική μορφή:
  • ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
  • Σύνθεση:
  • 0047931851 - CALCITONIN, SALMON - 100.000000 IU
  • Οδός χορήγησης:
  • ΕΝΔΟΜΥΙΚΗ ΧΟΡΗΓΗΣΗ, ΕΝΔΟΦΛΕΒΙΑ ΧΟΡΗΓΗΣΗ, ΥΠΟΔΟΡΙΑ ΧΟΡΗΓΗΣΗ
  • Τρόπος διάθεσης:
  • ΜΕ ΙΑΤΡΙΚΗ ΣΥΝΤΑΓΗ
  • Χρήση για:
  • Οι άνθρωποι
  • Τύπος φάρμακου:
  • αλλοπαθητική των ναρκωτικών

Έγγραφα

Εντοπισμός

  • Διατίθεται σε:
  • NORCALCIN 100 IU/AMP ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
    Ελλάδα
  • Γλώσσα:
  • Ελληνικά

Θεραπευτικές πληροφορίες

  • Θεραπευτική περιοχή:
  • CALCITONIN (SALMON SYNTHETIC)
  • Περίληψη προϊόντος:
  • 2802316502012 - 01 - BTX5(AMPX1ML) - 5.00 - ΧΙΛΙΟΣΤΟΛΙΤΡΟ - Εγκεκριμένο (ΕΟΦ) - ΦΑΡΜΑΚΕIOY

Άλλες πληροφορίες

Κατάσταση

  • Πηγή:
  • Εθνικός Οργανισμός Φαρμάκων
  • Καθεστώς αδειοδότησης:
  • Εγκεκριμένο (ΕΟΦ)
  • τελευταία ενημέρωση:
  • 09-01-2017

φύλλο οδηγιών χρήσης

Φύλλο Οδηγιών Για Το Χρήστη

1. ΠΡΟΣΔΙΟΡΙΣΜΟΣ ΦΑΡΜΑΚΕΥΤΙΚΟΥ ΠΡΟΪΟΝΤΟΣ    :  

1.1. NORCALCIN

Inj. Sol. 100IU/AMP  

1.2. Σύνθεση: Δραστική Ουσία:    Συνθετική καλσιτονίνη σολομού.

Έκδοχα    :   Glacial   Acetic   Acid,   Sodium   Acetate   Trihydrate, 

Sodium  Chloride,   Water   Purified   for   Injectiable 

Preparations.

1.3. Φαρμακοτεχνική Μορφή:      Ενέσιμο διάλυμα.

1.4. Περιεκτικότητα σε δραστική ουσία:

Κάθε φύσιγγα περιέχει 100IU συνθετικής καλσιτονίνης σολομού.

1.5. Περιγραφή – Συσκευασία:

5 γυάλινες φύσιγγες του 1ml, τοποθετημένες σε πλαστική θήκη συνοδευμένες από φύλλο οδηγιών 

χρήσης σε χάρτινο κουτί.

1.6. Φαρμακοθεραπευτική Κατηγορία:

Αντιπαραθυρεοειδής ορμόνη, κωδικός ATC:  H05BA01 (καλσιτονίνη σολομού).

1.7. Υπεύθυνος Κυκλοφορίας: BIOMEDICA – CHEMICA A.E.

(Γ. Λύρα 25 – Πάροδος Αγ. Φανουρίου

145 64 Κάτω Κηφισιά

Τηλέφωνα: 210 6200704–5

Fax: 210 6200706)

1.8. Παρασκευαστής - Συσκευαστής : BIOLOGICI ITALIA LABOR.

SRL, ITALY.

2.   ΤΙ  ΠΡΕΠΕΙ  ΝΑ  ΓΝΩΡΙΖΕΤΕ  ΓΙΑ  ΤΟ  ΦΑΡΜΑΚΟ  ΠΟΥ  ΣΑΣ  ΧΟΡΗΓΗΣΕ  

      Ο  ΓΙΑΤΡΟΣ  ΣΑΣ. 

2.1. Γενικές Πληροφορίες:

Το  NORCALCIN ενέσιμο  διάλυμα είναι  συνθετική  καλσιτονίνη  σολομού  η οποία  μοιάζει με  την 

φυσική ορμόνη καλσιτονίνη που βρίσκεται στον ανθρώπινο οργανισμό.   Η καλσιτονίνη ρυθμίζει τα 

επίπεδα του ασβεστίου στο αίμα, αναστρέφει την απώλεια οστού και βοηθά στο σχηματισμό νέου 

οστού.

Ο ακριβής μηχανισμός της δράσης του NORCALCIN δεν έχει πλήρως διευκρινιστεί.

Το πλεονέκτημα του σε σχέση με την ανθρώπινη καλσιτονίνη είναι ότι το αποτέλεσμα της δράσης του 

διαρκεί πολύ περισσότερο.

2.2. Ενδείξεις:

Το NORCALCIN ενδείκνυται για:

–  την πρόληψη της οξείας οστικής απώλειας λόγω αιφνίδιας ακινητοποίησης όπως στην    

    περίπτωση ασθενών με πρόσφατα οστεοπορωτικά κατάγματα.

–  τη νόσο του Paget.

–  την υπασβεστιαιμία από κακοήθεις όγκους.

2.3. Αντενδείξεις:

Τα φάρμακα μπορούν να βοηθήσουν τους ασθενείς, μπορούν όμως να δημιουργήσουν και προβλήματα 

όταν αυτά δεν λαμβάνονται σύμφωνα με τις οδηγίες.  Για το συγκεκριμένο φάρμακο θα πρέπει, πριν το 

πάρετε, να έχετε ενημερώσει το γιατρό σας για τις ακόλουθες περιπτώσεις:

Αν είχατε ποτέ αλλεργική αντίδραση ή κάποια ασυνήθιστη αντίδραση στο φάρμακο αυτό ή σε κάποια 

από τις ουσίες που περιέχονται στο φάρμακο.

Η καλσιτονίνη αντενδείκνυται επίσης σε ασθενείς με υπασβεστιαιμία.

2.4. Ειδικές προφυλάξεις και προειδοποιήσεις κατά τη χρήση:

2.4.1. Γενικά:

Επειδή η καλσιτονίνη είναι πεπτίδιο, υπάρχει η πιθανότητα συστηματικών αλλεργικών αντιδράσεων 

και   σε   ασθενείς   που   ελάμβαναν   καλσιτονίνη,   έχουν   αναφερθεί   αλλεργικού   τύπου   αντιδράσεις 

συμπεριλαμβανομένων μεμονωμένων περιπτώσεων αναφυλακτικής κατέρειψης.  Τέτοιες αντιδράσεις 

πρέπει να διαφοροποιούνται από τη γενικευμένη ή την τοπική έξαψη που είναι συνήθης με αλλεργικού 

τύπου   δράση   της   καλσιτονίνης.   Σε   ασθενείς   για   τους   οποίους   υπάρχει   υποψία   ευαισθησίας   στην 

καλσιτονίνη θα πρέπει να εξετάζεται η διενέργεια δερματικής δοκιμασίας πριν την αγωγή τους με 

καλσιτονίνη.

2.4.2. Ηλικιωμένοι:

Η εμπειρία με τη χρήση της καλσιτονίνης σε ηλικιωμένους (άνω των 65 ετών) δεν έδειξε μειωμένη 

ανοχή ή ανάγκη για τροποποίηση της δοσολογίας.

2.4.3. Ασθενείς με ηπατική ή νεφρική ανεπάρκεια:

Η εμπειρία με τη χρήση του NORCALCIN σε ασθενείς  με διαταραγμένη ηπατική λειτουργία δεν 

έδειξε μειωμένη ανοχή ή ανάγκη για τροποποίηση της δοσολογίας.

Η   μεταβολική   κάθαρση   είναι   κατά   πολύ   μικρότερη   σε   ασθενείς   με   νεφρική   ανεπάρκεια   τελικού 

σταδίου απ’ ότι σε υγιή άτομα.  Εντούτοις, η κλινική σημασία αυτού του ευρήματος δεν είναι γνωστή.

2.4.4. Κύηση:

Το NORCALCIN δεν έχει μελετηθεί σε έγκυες γυναίκες.  Η καλσιτονίνη θα πρέπει να χρησιμοποιείται 

κατά τη διάρκεια της κύησης μόνο εάν η θεραπεία θεωρηθεί απολύτως απαραίτητη από το γιατρό.  Αν 

μείνετε έγκυος κατά τη διάρκεια της θεραπείας με NORCALCIN ενημερώστε τον γιατρό σας.   

2.4.5. Γαλουχία:

Δεν είναι γνωστό εάν η ουσία απεκκρίνεται στο μητρικό γάλα.  Στα ζώα, η καλσιτονίνη σολομού έχει 

δειχθεί ότι μειώνει τη γαλουχία και ότι απεκκρίνεται στο γάλα.  Γι’ αυτόν τον λόγο ο θηλασμός δεν 

συνιστάται κατά τη διάρκεια της αγωγής.

2.4.6. Παιδιά:

Χορηγείται μόνο σε άτομα ηλικίας 18 ετών και άνω. 

Δεν συνιστάται η χρήση της καλσιτονίνης σολομού σε παιδιά.

2.4.7. Επίδραση στην ικανότητα οδήγησης και χειρισμού μηχανημάτων:

Δεν υπάρχουν δεδομένα για την επίδραση του ενέσιμου διαλύματος NORCALCIN στην ικανότητα 

οδήγησης και στο χειρισμό μηχανών.  Η ενέσιμη καλσιτονίνη μπορεί να προκαλέσει παροδική ζάλη, 

που μπορεί να μειώσει  της αντιδράσεις  του  ασθενούς.   Οι ασθενείς  πρέπει γι’ αυτόν το λόγο να  

προειδοποιούνται,   ότι   μπορεί   να   παρουσιασθεί   παροδική   ζάλη,   ώστε   να   μην   οδηγούν   ή   να   μην 

χειρίζονται μηχανές.

2.5. Αλληλεπιδράσεις με άλλα φαρμακευτικά προϊόντα και άλλες μορφές αλληλεπίδρασης:

Τα επίπεδα του ασβεστίου του ορού είναι δυνατόν να μειωθούν  παροδικά σε τιμές  κάτω από τις 

φυσιολογικές  μετά  από τη χορήγηση NORCALCIN, ιδιαίτερα  κατά την έναρξη  της  θεραπείας  σε 

ασθενείς   με   παθολογικούς   ρυθμούς   οστικής   απορρόφησης.     Η   δράση   αυτή   ελαττώνεται   καθώς 

μειώνεται η οστεοκλαστική δραστηριότητα.  Εντούτοις, θα πρέπει να δοθεί προσοχή σε ασθενείς που 

λαμβάνουν ταυτόχρονα αγωγή με καρδιακές γλυκοσίδες ή με αναστολείς των διαύλων ασβεστίου. 

Ενδέχεται ν’ απαιτηθεί ρύθμιση στη δοσολογία των φαρμάκων αυτών, λαμβάνοντας υπόψη το γεγονός 

ότι   οι   δράσεις   τους   είναι   δυνατό   να   τροποποιηθούν   λόγω   μεταβολών   των   συγκεντρώσεων   των 

ενδοκυττάριων ηλεκτρολυτών.

Η χρήση της καλσιτονίνης σε συνδυασμό με διφωσφονικά μπορεί να έχει ως αποτέλεσμα αθροιστική 

δράση στη μείωση του ασβεστίου.

2.6. Δοσολογία και τρόπος χορήγησης:

Χορηγείται σε άτομα ηλικίας 18 ετών και άνω με υποδόρια ή ενδομυϊκή ένεση ή ενδοφλέβια έγχυση 

(ανάλογα με το προϊόν).

Το NORCALCIN μπορεί να χορηγείται κατά την νυκτερινή κατάκλιση για τη μείωση της συχνότητας 

εμφάνισης ναυτίας ή εμέτου που μπορεί να εμφανισθούν, ειδικότερα κατά την έναρξη της θεραπείας.

Πρόληψη της οξείας οστικής απώλειας:

Η συνιστώμενη δοσολογία είναι 100IU την ημέρα ή 50IU δύο φορές την ημέρα για 2 έως 4 εβδομάδες, 

χορηγούμενη υποδόρια ή ενδομυϊκά.  Η δόση μπορεί να μειωθεί σε 50IU ημερησίως κατά την έναρξη 

της   επανακινητοποίησης   του   ασθενούς.   Η   θεραπευτική   αγωγή   δίδεται   μέχρις   ότου   οι   ασθενείς 

κινητοποιηθούν πλήρως.

Νόσος του     Paget    :  

Η   συνιστώμενη   δοσολογία   είναι   100  IU  ημερησίως   που   χορηγούνται   υποδόρια   ή   ενδομυϊκά. 

Εντούτοις έχει επιτευχθεί κλινική και βιοχημική βελτίωση και με την ελάχιστη δοσολογία των 50IU 

τρεις φορές την εβδομάδα.   Η δοσολογία θα πρέπει να εξατομικεύεται ανάλογα με τις ανάγκες του 

ασθενούς.  Η διάρκεια της αγωγής εξαρτάται από την ένδειξη της θεραπείας και την ανταπόκριση του 

ασθενούς.     Η  δράση  της   καλσιτονίνης  είναι  δυνατόν  να  αξιολογηθεί   με   τη  μέτρηση  κατάλληλων 

δεικτών   της   οστικής   αναδόμησης,   όπως   αλκαλική   φωσφατάση   του   ορού   ή   υδροξυπρολίνη   ή 

δεοξυπρολίνη των ούρων.  Η δόση μπορεί να μειωθεί όταν βελτιώνεται η κατάσταση του ασθενούς.

Υπερασβεστιαιμία από κακοήθεις όγκους:

Η συνιστώμενη δόση είναι 100IU κάθε 6 έως 8 ώρες με υποδόρια ή ενδομυϊκή ένεση.  Επιπρόσθετα, η 

καλσιτονίνη σολομού μπορεί να χορηγείται με ενδοφλέβια ένεση αφού προηγηθεί επανυδάτωση.

Εάν η ανταπόκριση δεν είναι ικανοποιητική μετά από μία ή δύο ημέρες, η δόση μπορεί ν’ αυξάνεται 

έως τη μέγιστη, 400IU  κάθε 6 έως 8 ώρες.   Σε σοβαρές ή επείγουσες περιπτώσεις είναι δυνατό να 

χορηγηθεί με ενδοφλέβια έγχυση μέχρι 10IU/Kg σωματικού βάρους σε 500ml διαλύματος χλωριούχου 

νατρίου 0,9% w/v για διάστημα τουλάχιστον 6 ωρών.

Χρήση σε ηλικιωμένους, σε ασθενείς με έκπτωση της ηπατικής και νεφρικής λειτουργίας:

Η εμπειρία με τη χρήση του NORCALCIN σε ηλικιωμένους δεν έδειξε μειωμένη ανοχή ή ανάγκη για 

τροποποίηση της δοσολογίας.   Το ίδιο ισχύει σε ασθενείς με διαταραγμένη ηπατική λειτουργία.   Η 

μεταβολική κάθαρση είναι κατά πολύ μικρότερη σε ασθενείς με νεφρική ανεπάρκεια τελικού σταδίου 

απ’ ότι σε υγιή άτομα.  Εντούτοις, η κλινική σημασία αυτού του ευρήματος δεν είναι γνωστή.

2.7. Υπερδοσολογία – Αντιμετώπιση    :  

Ναυτία,   έμετος,   ερύθημα   και   ζάλη   είναι   γνωστό   ότι   είναι   δοσοεξαρτώμενα   συμπτώματα   όταν   η 

καλσιτονίνη χορηγείται παρεντερικά.  Έχουν χορηγηθεί εφ άπαξ δόσεις (μέχρι 10.000IU) της ενέσιμης 

καλσιτονίνης σολομού χωρίς άλλες ανεπιθύμητες αντιδράσεις εκτός της ναυτίας και του έμετου, καθώς 

και την επίταση των φαρμακολογικών δράσεων. Η αντιμετώπιση πρέπει να είναι συμπτωματική όταν 

εμφανισθούν συμπτώματα υπερδοσολογίας. 

(Τηλέφωνο Κέντρου Δηλητηριάσεων 210–7793777).

2.8. Ανεπιθύμητες Ενέργειες:

Κατηγορίες βάσει συχνότητας:

Πολύ   συχνές   >1/10,   συχνές   (>1/100,   <1/10),   όχι   συχνές   (>1/1000,   <1/100),   σπάνιες   (>1/10000, 

<1/1000), πολύ σπάνιες (<1/10000), συμπεριλαμβανομένων μεμονωμένων αναφορών.

Διαταραχές του γαστρεντερικού:

Πολύ συχνές: Ναυτία με ή χωρίς έμετο σημειώνεται στο 10% περίπου των ασθενών στους οποίους 

χορηγείται καλσιτονίνη.   Η δράση είναι πιο εμφανής κατά την έναρξη της θεραπείας και τείνει να 

μειωθεί ή να εξαφανισθεί με τη συνεχή χορήγηση ή τη μείωση της δόσης.  Εάν απαιτείται μπορεί να 

χορηγηθεί ένα αντιεμετικό.  Ναυτία/έμετος είναι λιγότερο συχνά όταν η ένεση χορηγείται το βράδυ και 

μετά τα γεύματα.   

Όχι συχνές: Διάρροια.

Αγγειακές διαταραχές:

Πολύ   συχνές:   Εξάψεις   του   δέρματος   (προσώπου   και   άνω   κορμού).     Αυτές   δεν   είναι   αλλεργικές 

αντιδράσεις αλλά οφείλονται σε μία φαρμακολογική δράση και συνήθως παρατηρούνται 10 έως 20 

λεπτά μετά τη χορήγηση.

Γενικές διαταραχές και καταστάσεις της οδού χορήγησης:

Όχι συχνές: Τοπικές φλεγμονώδεις αντιδράσεις στο σημείο της υποδόριας ή της ενδομυϊκής ένεσης.

Διαταραχές του δέρματος και υποδόριου ιστού:

Όχι συχνές: Δερματικό εξάνθημα.

Διαταραχές του μυοσκελετικού συστήματος:

Συχνές: Μυοσκελετικός πόνος.

Όχι συχνές: Αρθραλγία.

Διαταραχές του νευρικού συστήματος:

Όχι συχνές: Μεταλλική γεύση στο στόμα, ζάλη.

Διαταραχές των νεφρών και των ουροφόρων οδών:

Όχι συχνές: Διούρηση.

Διαταραχές του μεταβολισμού και της θρέψης:

Σπάνιες: Σε περίπτωση ασθενών με υψηλή οστική αναδόμηση (νόσο του Paget και νεαροί ασθενείς) 

παροδική, συνήθως ασυμπτωματική, μείωση της ασβεστιαιμίας μπορεί να εμφανισθεί μεταξύ της 4 ης 

και 6 ης  ώρας μετά τη χορήγηση.

Διαταραχές του ανοσοποιητικού συστήματος:

Πολύ σπάνιες: Σοβαρές αλλεργικού τύπου αντιδράσεις όπως βρογχόσπασμος, οίδημα της γλώσσας και 

του φάρυγγα και σε μεμονωμένες περιπτώσεις αναφυλαξία.

Έρευνες:

Σπάνιες:   Ανάπτυξη   αντισωμάτων   που   αδρανοποιούν   την   καλσιτονίνη.     Η   ανάπτυξη   αυτών   των 

αντισωμάτων δεν σχετίζεται συνήθως με την απώλεια της κλινικής αποτελεσματικότητας, αν και η 

παρουσία   τους   σε   μικρό   ποσοστό   ασθενών   μετά   από   μακροχρόνια   θεραπεία   με   υψηλές   δόσεις 

καλσιτονίνης  μπορεί  να  έχει   ως   αποτέλεσμα   τη μειωμένη   ανταπόκριση  στο προϊόν.   Η  παρουσία 

αντισωμάτων  φαίνεται  να μη συσχετίζεται  με αλλεργικές  αντιδράσεις  οι οποίες  είναι σπάνιες.   Η 

ρύθμιση   προς   τα   κάτω   των   υποδοχέων   της   καλσιτονίνης   μπορεί   επίσης   να   έχει   ως   αποτέλεσμα 

μειωμένη κλινική ανταπόκριση σε μικρό ποσοστό ασθενών μετά από μακροχρόνια θεραπεία με υψηλές 

δόσεις.

Αν εμφανίσετε κάποια από αυτές τις ανεπιθύμητες ενέργειες ή κάποια άλλη που δεν αναφέρεται στο 

φύλλο οδηγιών ενημερώστε τον γιατρό σας.

2.9. Τι πρέπει να γνωρίζετε σε περίπτωση που παραλείψετε να πάρετε κάποια δόση:

Πάρτε τη δόση που παραλείψατε μόλις το θυμηθείτε, εκτός αν έχουν μείνει λιγότερο από 4 ώρες πριν 

την επόμενη.  Σε αυτή την περίπτωση πάρτε την επόμενη δόση στην κανονική ώρα.   

2.10. Ημερομηνία λήξης του προϊόντος:

Αναγράφεται στην εσωτερική και εξωτερική συσκευασία.

Σε περίπτωση που η ημερομηνία αυτή έχει παρέλθει μην το χρησιμοποιείτε.

2.11. Ιδιαίτερες προφυλάξεις για τη φύλαξη του προϊόντος: Καμία.

2.12. Ημερομηνία τελευταίας αναθεώρησης του φύλλου οδηγιών: 03/2011

3. ΠΛΗΡΟΦΟΡΙΕΣ  ΓΙΑ  ΤΗΝ  ΟΡΘΟΛΟΓΙΚΗ ΧΡΗΣΗ  ΤΩΝ  ΦΑΡΜΑΚΩΝ

Το φάρμακο αυτό σας το έγραψε ο γιατρός μόνο για το συγκεκριμένο ιατρικό σας πρόβλημα. Δεν θα πρέπει 

να το δίνετε σε άλλα άτομα ή να το χρησιμοποιείτε για κάποια άλλη πάθηση, χωρίς προηγουμένως να έχετε 

συμβουλευτεί το γιατρό σας.

Εάν κατά τη διάρκεια της θεραπείας εμφανιστεί κάποιο πρόβλημα με το φάρμακο, ενημερώστε αμέσως το 

γιατρό σας ή το φαρμακοποιό σας.

Εάν έχετε οποιαδήποτε ερωτηματικά γύρω από τις πληροφορίες που αφορούν το φάρμακο που λαμβάνετε ή 

χρειάζεστε, καλύτερη ενημέρωση για το ιατρικό σας πρόβλημα μη διστάσετε να ζητήσετε τις πληροφορίες 

αυτές από το γιατρό σας ή τον φαρμακοποιό σας.

Για να είναι αποτελεσματικό και ασφαλές το φάρμακο που σας χορηγήθηκε, θα πρέπει να λαμβάνεται 

σύμφωνα  με τις οδηγίες που σας δόθηκαν.

Για την ασφάλεια σας και την υγεία σας, είναι απαραίτητο να διαβάσετε με προσοχή κάθε πληροφορία που 

αφορά το φάρμακο που σας χορηγήθηκε.

Να   μην   διατηρείτε   τα   φάρμακα   σε   ερμάρια   του   λουτρού,   διότι   η   ζέστη   και   η   υγρασία     μπορεί   να 

αλλοιώσουν το φάρμακο και να το καταστήσουν επιβλαβές για την υγεία σας.

Να μην κρατάτε φάρμακα που δεν χρειάζεστε πλέον ή που έχουν λήξει.

Για μεγαλύτερη ασφάλεια κρατάτε όλα τα φάρμακα σε ασφαλές μέρος μακριά από τα παιδιά.

4.       Τρόπος διάθεσης:  

Το φάρμακο αυτό χορηγείται με απλή ιατρική συνταγή.

13-11-2018

Alebrije Dist Wholesale Recalls Quesillo Queseria “La Milagrosa” and “Alebrije Cheese” Because of Possible Health Risk

Alebrije Dist Wholesale Recalls Quesillo Queseria “La Milagrosa” and “Alebrije Cheese” Because of Possible Health Risk

ALEBRIJE DIST WHOLESALE is collaborating with health officials due to a positive finding of Salmonella in a sample of Quesillo “Queseria La Milagrosa”. ALEBRIJE DIST WHOLESALE is voluntarily recalling the amount of 100 kilos of Quesillo “Queseria La Milagrosa”. While “Alebrije Cheese” has not been found positive for Salmonella, ALEBRIJE DIST WHOLESALE has decided to voluntarily recall the specific 498 “Alebrije Cheese” pieces that were imported during the same period out of an abundance of caution.

FDA - U.S. Food and Drug Administration

6-11-2018

FDA Investigating Recalled Duncan Hines Cake Mixes Potentially Linked to Salmonella Agbeni Illnesses

FDA Investigating Recalled Duncan Hines Cake Mixes Potentially Linked to Salmonella Agbeni Illnesses

The FDA is investigating the manufacturing facility that made recalled Duncan Hines cake mixes.

FDA - U.S. Food and Drug Administration

6-11-2018

Duncan Hines Classic White, Classic Butter Golden, Signature Confetti and Classic Yellow Cake Mixes Recalled Due to Potential Presence of Salmonella

Duncan Hines Classic White, Classic Butter Golden, Signature Confetti and Classic Yellow Cake Mixes Recalled Due to Potential Presence of Salmonella

Conagra Brands is collaborating with health officials in connection with a positive finding of Salmonella in a retail sample of Duncan Hines Classic White cake mix that may be linked to a Salmonella outbreak that is currently being investigated by CDC and FDA. While it has not been definitively concluded that this product is linked to the outbreak and the investigation is still ongoing, Conagra has decided to voluntarily recall the specific Duncan Hines variety identified (Classic White) and three other ...

FDA - U.S. Food and Drug Administration

2-11-2018

Barcelona Nut Company Recalls Roasted and Salted in Shell Pistachios Because of Possible Health Risk

Barcelona Nut Company Recalls Roasted and Salted in Shell Pistachios Because of Possible Health Risk

Barcelona Nut Company of Baltimore, Maryland is recalling 239 cases of roasted and salted in shell pistachios, because it has the potential to be contaminated with Salmonella, an organism that can cause serious and sometimes-fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain.

FDA - U.S. Food and Drug Administration

30-10-2018

Food Recall of Fit & Active Southwest Veggie Stuffed Sandwiches Due to Possible Listeria monocytogenes and Salmonella Contamination in Vegetables

Food Recall of Fit & Active Southwest Veggie Stuffed Sandwiches Due to Possible Listeria monocytogenes and Salmonella Contamination in Vegetables

J&J Snack Foods Handheld Corp. of Holly Ridge, NC is voluntarily recalling two lots of Fit & Active Southwest Veggie Stuffed Sandwiches due to potential contamination with Listeria monocytogenes and Salmonella. Salmonella is an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

FDA - U.S. Food and Drug Administration

26-10-2018

Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products

Multi-country outbreak of Listeria monocytogenes sequence type 8 infections linked to consumption of salmon products

Published on: Thu, 25 Oct 2018 00:00:00 +0200 A multi-country outbreak of 12 listeriosis cases caused by Listeria monocytogenes sequence type (ST) 8 has been identified through whole genome sequencing (WGS) analysis in three EU/EEA countries: Denmark (6 cases), Germany (5) and France (1). Four of these cases have died due to or with the disease. It is likely that the extent of this outbreak has been underestimated since the outbreak was identified through sequencing and only a subset of the EU/EEA count...

Europe - EFSA - European Food Safety Authority Publications

25-10-2018

Multi-country outbreak of Listeria monocytogenes linked to consumption of salmon products

Multi-country outbreak of Listeria monocytogenes linked to consumption of salmon products

Multi-country outbreak of Listeria monocytogenes linked to consumption of salmon products

Europe - EFSA - European Food Safety Authority Press Releases & News Stories

19-10-2018

Hy-Vee Voluntarily Recalls Several Meat and Potato Products

Hy-Vee Voluntarily Recalls Several Meat and Potato Products

Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling six of its meat and potato products across its eight-state region due to possible contamination with Salmonella and Listeria monocytogenes. The potential for contamination was discovered after Hy-Vee’s supplier, McCain Foods, announced it was recalling its caramelized mushrooms and fire-roasted tomatoes, which are ingredients that are used in six Hy-Vee products. To date, no illnesses have been reported in connection with these prod...

FDA - U.S. Food and Drug Administration

10-10-2018

Bazzini LLC Recalls Certain Pistachio Products Because of Possible Health Risk

Bazzini LLC Recalls Certain Pistachio Products Because of Possible Health Risk

BazziniI LLC of Allentown, PA out of an abundance of caution, is recalling 4,000 pounds of Roasted and Salted Colossal Natural, Super Colossal Natural and Rams Head Natural in Shell Pistachios received from one of its suppliers because it has the potential to be contaminated with Salmonella. NO OTHER BAZZINI PISTACHIOS OR BAZZINI PRODUCTS ARE IMPACTED OR PART OF THIS RECALL. The recall is being initiated voluntarily and no illnesses have been reported to date.

FDA - U.S. Food and Drug Administration

9-10-2018

Notice of call for expressions of interest - Salmonella molecular serotyping

Notice of call for expressions of interest - Salmonella molecular serotyping

France - Agence Nationale du Médicament Vétérinaire

20-9-2018

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Report of the third Joint Meeting of the ECDC's Food‐ and Waterborne Diseases and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network

Published on: Wed, 19 Sep 2018 00:00:00 +0200 The third Joint Meeting of the ECDC's Food‐ and Waterborne Disease and Zoonoses Network and of the EFSA's Zoonoses Monitoring Data Network was held on 16 and 17 October 2017 in Parma. The meeting was constructed around the principle of ‘One health approach to collaborative response to foodborne disease outbreaks in EU/EEA’ and served as an opportunity for public health authorities and food safety/veterinary authorities to meet and exchange information on the...

Europe - EFSA - European Food Safety Authority Publications

13-9-2018

Bravo Packing, Inc. Recalls Performance Dog Raw Pet Food Because of Possible Salmonella Health Risk to Humans and Animals

Bravo Packing, Inc. Recalls Performance Dog Raw Pet Food Because of Possible Salmonella Health Risk to Humans and Animals

Bravo Packing, Inc. of Carneys Point, NJ is recalling all Performance Dog products, a frozen raw pet food, because it has the potential to be contaminated with Salmonella. Salmonella can cause illness in animals eating the products, as well as people who handle contaminated pet products, especially if they have not thoroughly washed their hands after having contact with the products, infected animals or any surfaces exposed to these products.

FDA - U.S. Food and Drug Administration

10-9-2018

FDA Investigating Multistate Outbreak of Salmonella Enteritidis Linked to Shell Eggs from Gravel Ridge Farms

FDA Investigating Multistate Outbreak of Salmonella Enteritidis Linked to Shell Eggs from Gravel Ridge Farms

Outbreak of Salmonella Enteritidis Linked to Shell Eggs

FDA - U.S. Food and Drug Administration

8-9-2018

Steve’s Real Food Voluntarily Recalls One Lot of Turducken Recipe, One Lot of Quest Emu, and One Lot of Quest Beef Due to Possible Salmonella and L. Mono Contamination

Steve’s Real Food Voluntarily Recalls One Lot of Turducken Recipe, One Lot of Quest Emu, and One Lot of Quest Beef Due to Possible Salmonella and L. Mono Contamination

Steve’s Real Food of Salt Lake City, Utah is voluntarily recalling one lot of 5lb Turducken Recipe, one lot of 2lb Quest Emu Diet, and one lot of 2lb Quest Beef Diet, due to their possible Salmonella and/or L. mono contamination.

FDA - U.S. Food and Drug Administration

8-9-2018

Gravel Ridge Farms Recalls Cage Free Egg Due to Possible Salmonella Contamination

Gravel Ridge Farms Recalls Cage Free Egg Due to Possible Salmonella Contamination

Gravel Ridge Farms is recalling Cage Free Large Eggs due to a potential contamination of Salmonella. The recall was initiated because reported illnesses were confirmed at locations using Gravel Ridge Farm Eggs, and we are voluntarily recalling out of an abundance of caution.

FDA - U.S. Food and Drug Administration

16-8-2018

Zakah Life Recalls Kratom Because Of Possible Health Risk

Zakah Life Recalls Kratom Because Of Possible Health Risk

Zakah Life, LLC of Ankeny, Iowa, is recalling the following Kratom products (Super Green Maeng Da Premium Kratom powder, Powerful Red Vein Bali Premium Kratom powder, Super Green Maeng Da Premium Kratom capsules, and Powerful Red Vein Bali Premium Kratom capsules) with expiration dates prior to 01/01/2023 because they have the potential of being contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weak...

FDA - U.S. Food and Drug Administration

14-8-2018

World Organix, LLC Issues Voluntary Nationwide Recall of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend, Due to High Microbial Loads

World Organix, LLC Issues Voluntary Nationwide Recall of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend, Due to High Microbial Loads

World Organix LLC, is voluntarily recalling lot: 112710 of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa capsules, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend to the consumer level. These products have been tested by the U.S. Food and Drug Administration (“FDA”) and found to be contaminated with High Microbial Loads. Additionally, this serves as a update to a previous press release posted on June 30th 2018, concerning Blissful...

FDA - U.S. Food and Drug Administration

26-7-2018

Multi country Salmonella Agona outbreak possibly linked to ready-to-eat food

Multi country Salmonella Agona outbreak possibly linked to ready-to-eat food

Multi country Salmonella Agona outbreak possibly linked to ready-to-eat food

Europe - EFSA - European Food Safety Authority Press Releases & News Stories

25-7-2018

AMPI Recalls Limited Amount of Dry Whey Powder Because of Possible Health Risk

AMPI Recalls Limited Amount of Dry Whey Powder Because of Possible Health Risk

Associated Milk Producers Inc. (AMPI) of New Ulm, Minn., is recalling dry whey powder packaged in 50-pound and 25-kg bags that were produced at the cooperative’s Blair, Wis., dry whey plant from May 1-5, 2018; May 24-29, 2018; June 2-5, 2018; and June 7-14, 2018 due to the potential to be contaminated with Salmonella. This is a precautionary recall. All products shipped to the marketplace tested negative for Salmonella.

FDA - U.S. Food and Drug Administration

24-7-2018

Pepperidge Farm® Announces Voluntary Recall of Four Varieties of Goldfish® Crackers

Pepperidge Farm® Announces Voluntary Recall of Four Varieties of Goldfish® Crackers

Pepperidge Farm has been notified by one of its ingredient suppliers that whey powder in a seasoning that is applied to four varieties of crackers has been the subject of a recall by the whey powder manufacturer due to the potential presence of Salmonella. Pepperidge Farm initiated an investigation and, out of an abundance of caution, is voluntarily recalling four varieties of Goldfish crackers. The products were distributed throughout the United States. No illnesses have been reported. ...

FDA - U.S. Food and Drug Administration

24-7-2018

Statement from FDA Commissioner Scott Gottlieb, M.D. on voluntary recalls of Ritz, Goldfish and other products issued out of an abundance of caution

Statement from FDA Commissioner Scott Gottlieb, M.D. on voluntary recalls of Ritz, Goldfish and other products issued out of an abundance of caution

The U.S. Food and Drug Administration is working with Mondelēz International, Inc., Pepperidge Farm Inc. and Flowers Foods, Inc. to initiate voluntarily recalls of certain products due to a potential risk that one of the ingredients may have been contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

23-7-2018

Flowers Foods Issues Voluntary Recall on Mrs. Freshley’s and Other Brands of Swiss Rolls and Captain John Derst’s Old Fashioned Bread

Flowers Foods Issues Voluntary Recall on Mrs. Freshley’s and Other Brands of Swiss Rolls and Captain John Derst’s Old Fashioned Bread

As a precautionary measure, Flowers Foods, Inc. (NYSE: FLO) is voluntarily recalling Swiss Rolls sold under the brand names Mrs. Freshley’s, Food Lion, H-E-B, Baker’s Treat, Market Square, and Great Value, distributed nationwide, and Captain John Derst’s Old Fashioned Bread distributed in Alabama, Florida, Georgia, North Carolina, and South Carolina, due to the potential presence of Salmonella in an ingredient, whey powder. The ingredient recall was initiated by a third-party whey powder manufacturer and...

FDA - U.S. Food and Drug Administration

23-7-2018

Mondelēz Global LLC Conducts Voluntary Recall of Certain Ritz Cracker Sandwiches and Ritz Bits Product in the U.S., including Puerto Rico & U.S. Virgin Islands Due to Possible Health Risk

Mondelēz Global LLC Conducts Voluntary Recall of Certain Ritz Cracker Sandwiches and Ritz Bits Product in the U.S., including Puerto Rico & U.S. Virgin Islands Due to Possible Health Risk

Mondelēz Global LLC announced today a voluntary recall in the United States, including Puerto Rico & the U.S. Virgin Islands, of certain Ritz Cracker Sandwiches and Ritz Bits product. These products contain whey powder as an ingredient, which the whey powder supplier has recalled due to the potential presence of Salmonella.

FDA - U.S. Food and Drug Administration

18-7-2018

FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

FDA Investigating Multistate Outbreak of Salmonella Sandiego Infections Linked to Hy-Vee Spring Pasta Salad

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, is investigating a multi-state outbreak of Salmonella Sandiego illnesses linked to Spring Pasta Salad sold at Hy-Vee locations in Iowa, Illinois, Kansas, Minnesota, Missouri, Nebraska, South Dakota, and Wisconsin.

FDA - U.S. Food and Drug Administration

18-7-2018

Hy-Vee Voluntarily Recalls Spring Pasta Salad Due to Reported Illnesses

Hy-Vee Voluntarily Recalls Spring Pasta Salad Due to Reported Illnesses

WEST DES MOINES, Iowa (July 17, 2018) — Hy-Vee, Inc., based in West Des Moines, Iowa, is voluntarily recalling its Hy-Vee Spring Pasta Salad due to the potential that it may be contaminated with Salmonella. The potential for contamination was brought to Hy-Vee’s attention last night when approximately 20 illnesses in Minnesota, South Dakota, Nebraska and Iowa were potentially linked back to customers consuming the salad. The voluntary recall includes Hy-Vee Spring Pasta Salads in both 1 pound (16 oz.) an...

FDA - U.S. Food and Drug Administration

2-7-2018

Blissful Remedies Issues Voluntary Nationwide Recall of Certain Kratom Powder Capsule

Blissful Remedies Issues Voluntary Nationwide Recall of Certain Kratom Powder Capsule

Blissful Remedies., is voluntarily recalling only Lot No.: 112710 with expiration 03/2019 found embedded on the top of package of kratom ( mitragyn a speciosa) powder products, it manufactured, processed, packed, and/or held, between “March 1, 2018” to “April 30, 2018” to the consumer level. The products have been found by the U.S. Food and Drug Administration (“FDA”) via sample testing to have salmonella contamination. Blissful Remedies has not received reports of adverse events related to this recall. ...

FDA - U.S. Food and Drug Administration

22-6-2018

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination

The products have been found by the FDA via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordance to FDA guidelines

FDA - U.S. Food and Drug Administration

21-6-2018

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., Voluntarily Recalls Kratom Products Due to Potential Salmonella Contamination

Gaia Ethnobotanical, LLC., is voluntarily recalling all kratom (mitragyna speciosa) powder products, with Lot No.: 0102031800 it manufactured, processed, packed, and/or held, between March 18, 2018 to March 30, 2018 to the consumer level. The products have been found by the U.S. Food and Drug Administration (“FDA”) via sample testing and finding to have salmonella contamination. In lieu of such FDA findings the company has implemented standard operating procedures and sterilization processes in accordanc...

FDA - U.S. Food and Drug Administration

21-6-2018

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

Now Health Group Inc. Recalls Select Now Real Food® Zesty Sprouting Mix Because of Possible Health Risk

NOW Health Group, Inc. (NOW), of Bloomingdale, Illinois, is recalling its NOW Real Food® Zesty Sprouting Mix – Product Code 7271, Lot #3031259 and Lot #3038165 – because its primary ingredient, Crimson Clover Seeds, has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may b...

FDA - U.S. Food and Drug Administration

15-6-2018

FDA Investigating Multistate Outbreak of Salmonella Mbandaka Infections Likely Linked to Kellogg’s Honey Smacks Cereal

FDA Investigating Multistate Outbreak of Salmonella Mbandaka Infections Likely Linked to Kellogg’s Honey Smacks Cereal

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, are investigating a multistate outbreak of Salmonella Mbandaka illnesses that may be linked to Kellogg’s Honey Smacks cereal.

FDA - U.S. Food and Drug Administration

15-6-2018

Kellogg Company Voluntarily Recalls Honey Smacks Cereal Due to Possible Health Risk

Kellogg Company Voluntarily Recalls Honey Smacks Cereal Due to Possible Health Risk

Kellogg Company today announced it is voluntarily recalling 15.3 oz. and 23 oz. packages of Kellogg’s® Honey Smacks® cereal (with code dates listed below) because these products have the potential presence of Salmonella. No other Kellogg products are impacted by this recall.

FDA - U.S. Food and Drug Administration

9-6-2018

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods, LLC Voluntarily Recalls Fresh Cut Melon Products Because of Possible Health Risk

Caito Foods is voluntarily recalling fresh cut watermelon, honeydew melon, cantaloupe and fresh-cut mixed fruit containing one of these melons, produced at the Caito Foods facility in Indianapolis, because these products have the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

9-6-2018

FDA Investigating Multistate Outbreak of Salmonella Adelaide Infections Linked to Pre-Cut Melons

FDA Investigating Multistate Outbreak of Salmonella Adelaide Infections Linked to Pre-Cut Melons

The U.S. Food and Drug Administration, along with the Centers for Disease Control and Prevention (CDC) and state and local partners, are investigating a multistate outbreak of Salmonella Adelaide illnesses that may be linked to cut melons.

FDA - U.S. Food and Drug Administration

29-5-2018

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion Voluntary Recall Due to Possible Health Risk

Pious Lion located in Asheville, NC is voluntarily recalling two of their Kratom products: Pious Lion Pure Premium Potent Limited Release Pink Bali, 1 oz and Pious Lion Pure Premium Potent White Maeng DA, Bright Uplifting Energy, 4 oz due to the presence of Salmonella . Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhe...

FDA - U.S. Food and Drug Administration

23-5-2018

Golden International Corporation  Issues Public Safety Warning For Stolen Tilapia Because  of Possible Health Risk

Golden International Corporation Issues Public Safety Warning For Stolen Tilapia Because of Possible Health Risk

Golden International Corporation of Renton, WA is issuing a public safety notice for 405 cartons of stolen frozen tilapia, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection wi...

FDA - U.S. Food and Drug Administration

21-5-2018

Ziyad Brothers Importing Recalls Tahini Because of Possible Health Risk

Ziyad Brothers Importing Recalls Tahini Because of Possible Health Risk

Ziyad Brothers Importing is voluntarily recalling certain lot codes of Ziyad Brand Tahini because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting, and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into ...

FDA - U.S. Food and Drug Administration

4-5-2018

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals Recalls Red Suma, Green Suma, Green Hulu 2, And Red Hulu 2 Kratom Supplements Because Of Possible Salmonella Health Risk

Badger Botanicals, LLC of Springville, Utah is recalling Green Suma, Red Suma, Green Hulu 2, and Red Hulu 2 kratom dietary supplements sold directly to consumers via the company website from January 1st, 2018 to April l 12th, 2018 in pouches of 250g, because it has the potential to be contaminated with Salmonella.

FDA - U.S. Food and Drug Administration

4-5-2018

Maya Distribution, LLC Recalls Dragon Label Kratom Because Of Possible Salmonella Contamination

Maya Distribution, LLC Recalls Dragon Label Kratom Because Of Possible Salmonella Contamination

Maya Distribution, LLC of South Salt Lake City, Utah is voluntarily recalling Dragon Kratom labeled bottles and sealed packages of encapsulated and raw powder product because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. 

FDA - U.S. Food and Drug Administration

3-5-2018

FDA Approves Application for AquaBounty Salmon Facility in Indiana

FDA Approves Application for AquaBounty Salmon Facility in Indiana

FDA approved a supplemental New Animal Drug Application submitted by AquaBounty Technologies, Inc. The supplemental NADA requested FDA approval to raise AquAdvantage Salmon at a land-based contained facility near Albany, Indiana.

FDA - U.S. Food and Drug Administration

24-4-2018

One lot of Traditional Medicinals "Throat Coat Lemon Echinacea" herbal tea recalled because of potential contamination with Salmonella

One lot of Traditional Medicinals "Throat Coat Lemon Echinacea" herbal tea recalled because of potential contamination with Salmonella

Health Canada is advising Canadians that one lot of “Throat Coat Lemon Echinacea” herbal tea is being voluntarily recalled by Traditional Medicinals after a company supplier found Salmonella contamination in a tea ingredient (lemon myrtle leaf). An infection caused by Salmonella bacteria may pose serious health risks, particularly for young children, pregnant women, the elderly and people with weak immune systems.

Health Canada

20-4-2018

Dietary Supplements by Nutrizone: Recall - Potential for Salmonella Contamination

Dietary Supplements by Nutrizone: Recall - Potential for Salmonella Contamination

Expanded recall of various kratom dietary supplements to additional lot numbers due to possible Salmonella Health Risk.

FDA - U.S. Food and Drug Administration

19-4-2018

Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Certain Kratom-Containing Powder Products by Viable Solutions: Recall -Possible Salmonella Contamination

Viable Solutions of Nampa, ID has initiated a recall of certain Kratom-containing powder products, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result...

FDA - U.S. Food and Drug Administration

19-4-2018

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NxtGen Botanicals Maeng Da Kratom by NGB Corp.: Recall - Possible Salmonella Contamination

NGB Corp. of West Jordan, Utah is voluntarily recalling NxtGen Botanicals Maeng Da Kratom labeled bottles of encapsulated product because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infec...

FDA - U.S. Food and Drug Administration

6-4-2018

"Organic Traditions Shatavari Powder" sold at Choices Markets Yaletown in Vancouver, B.C., contaminated with Salmonella

"Organic Traditions Shatavari Powder" sold at Choices Markets Yaletown in Vancouver, B.C., contaminated with Salmonella

Health Canada is advising Canadians that one lot of “Organic Traditions Shatavari Powder” is being voluntarily recalled by Advantage Health Matters Inc. Company testing found Salmonella bacteria contamination, which may pose serious health risks. According to Advantage Health Matters Inc., 13 units from the affected lot were distributed. Of the 13 units, only 2 packages, sold at Choices Markets Yaletown (1202 Richards Street) in Vancouver, B.C., have not been recovered.

Health Canada

22-8-2018

CLYNAV (Elanco GmbH)

CLYNAV (Elanco GmbH)

CLYNAV (Active substance: Salmon pancreas disease vaccine (recombinant DNA plasmid)) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5624 of Wed, 22 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2390/T/02

Europe -DG Health and Food Safety